Table 2

Change in cardiovascular risk factors and body composition over time

Exercise groupControl groupp Value (group×time interaction)
Baseline3 months6 monthsBaseline3 months6 months
Systolic BP (mm  Hg)130.9±12.5126.2±9.6*123.8±11.5**126.5±14.0128.1±12.9131.2±12.4*<0.001
Diastolic BP (mm  Hg)78.6±6.275.9±6.7*75.5±6.0*75.8±8.877.9±10.379.3±8.1*0.003
Triglycerides (mmol/l)1.5±0.61.4±0.91.2±0.5*1.6±0.91.6±1.01.7±0.90.031
TC (mmol/l)5.0±1.04.9±1.14.7±1.14.8±1.04.7±1.04.9±1.00.079
HDL (mmol/l)1.3±0.41.4±0.41.4±0.41.5±0.41.5±0.31.4±0.30.042
TC/HDL3.9±1.13.7±1.03.5±0.8*3.5±1.43.7±1.43.9±1.30.005
Insulin (pmol/l)65 (50.5–95.2)64.5 (44.3–104.8)66.4 (51.3–101.5)49 (21–90.2)48.7 (20.1–77.4)56.5 (21.5–104.5)0.192
HOMA2.5±1.62.2±1.52.4±1.31.7±1.21.7±0.81.5±0.80.098
QUICKI0.336±0.0500.342±0.0400.346±0.0330.360±0.0560.358±0.0270.368±0.0650.214
10-year CVD risk (%)1.0 (0–4.0)1.0 (0–3.8)1.0 (0–3.5)*1.0 (0–3.0)1.0 (0–5.0)1.0 (0–5.0)0.012
BMI (kg/m2)28.7±5.128.6±5.028.0±4.8*28.8±5.329.0±5.529.1±5.4<0.001
BF (%)36.1±8.434.8±8.3*33.6±7.9*37.2±8.737.4±8.138.3±7.9<0.001
HAQ1.4±0.81.0±0.6**0.9±0.6**1.3±0.71.6±0.51.5±0.60.003
DAS283.5±1.22.9±0.8*2.7±0.7*3.1±1.23.1±0.63.2±0.90.008
CRP3.0 (3.0–13.0)3.0 (3.0–4.0)4.0 (3.0–8.0)3.0 (3.0–7.7)5.0 (3.0–10.0)7.0 (3.0–15.0)0.042
  • Results expressed as mean±SD or median (range).

  • *Significant difference to baseline p<0.05 (repeated measures ANOVA).

  • **Significant difference to baseline p<0.001 (repeated measures ANOVA).

  • BF, body fat; BMI, body mass index; BP, blood pressure; Chol, cholesterol; CVD, cardiovascular disease risk; DAS28, Disease Activity Score 28; HAQ, Health Assessment Questionnaire; HDL, high density lipoprotein; HOMA, Homeostasis Model Assessment of Insulin Resistance; QUICKI, Quantitative Insulin Sensitivity Check Index; TC, total cholesterol.